The brain-derived neurotrophic factor Val66Met polymorphism is not associated with schizophrenia: An updated meta-analysis of 11,480 schizophrenia cases and 13,490 controls

Psychiatry Research

Volumn 225, Issue 1-2, 2015, Pages 217-220

  Zhao, Xiaofeng ^a   Huang, Yinglin ^b   Chen, Kaiyuan ^c   Li, Duolu ^a   Han, Chao ^a   Kan, Quancheng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

^c SHANDONG MENTAL HEALTH CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; VALINE;

ALLELE; CASE CONTROL STUDY; CAUCASIAN; CHINESE; DISEASE PREDISPOSITION; DSM-IV; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; JAPANESE (PEOPLE); LETTER; MAJOR CLINICAL STUDY; META ANALYSIS; RISK FACTOR; SCHIZOPHRENIA; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; GENETICS; STATISTICS;

BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; HUMANS; POLYMORPHISM, GENETIC; SCHIZOPHRENIA; STATISTICS AS TOPIC;

EID: 84916613850     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.11.015     Document Type: Letter

References (46)

1. Agartz I., Sedvall G.C., Terenius L., Kulle B., Frigessi A., Hall H., Jönsson E.G. BDNF gene variants and brain morphology in schizophrenia. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 2006, 141B:513-523.
2. Anttila S., Illi A., Kampman O., Mattila K.M., Lehtimaki T., Leinonen E. Lack of association between two polymorphisms of brain-derived neurotrophic factor and response to typical neuroleptics. Journal of Neural Transmission 2005, 112:885-890.
3. Chang H.A., Lu R.B., Shy M.J., Chang C.C., Lee M.S., Huang S.Y. Brain-derived neurotrophic factor Val66Met polymorphism: association with psychopathological symptoms of schizophrenia?. The Journal of Neuropsychiatry and Clinical Neurosciences 2009, 21:30-37.
4. Chen Q.Y., Chen Q., Feng G.Y., Wan C.L., Lindpaintner K., Wang L.J., Chen Z.X., Gao Z.S., Tang J.S., Li X.W., He L. Association between the brain-derived neurotrophic factor (BDNF) gene and schizophrenia in the Chinese population. Neuroscience Letters 2006, 397:285-290.
5. Chen S.L., Lee S.Y., Chang Y.H., Chen S.H., Chu C.H., Wang T.Y., Chen P.S., Lee I.H., Yang Y.K., Hong J.S., Lu R.B. The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2014, 51:99-104.
6. de Krom M., Bakker S.C., Hendriks J., van Elburg A., Hoogendoorn M., Verduijn W., Sinke R., Kahn R., Adan R.A. Polymorphisms in the brain-derived neurotrophic factor gene are not associated with either anorexia nervosa or schizophrenia in Dutch patients. Psychiatric Genetics 2005, 15:81.
7. Donohoe G., Morris D.W., Robertson I.H., Clarke S., McGhee K.A., Schwaiger S., Nangle J.M., Gill M., Corvin A. Variance in facial recognition performance associated with BDNF in schizophrenia. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 2007, 144B:578-579.
8. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
9. Gourion D., Goldberger C., Leroy S., Bourdel M.C., Olie J.P., Krebs M.O. Age at onset of schizophrenia: interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants. NeuroReport 2005, 16:1407-1410.
10. Gratacòs M., González J.R., Mercader J.M., de Cid R., Urretavizcaya M., Estivill X Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biological Psychiatry 2007, 61:911-922.
11. Gruber O., Hasan A., Scherk H., Wobrock T., Schneider-Axmann T., Ekawardhani S., Schmitt A., Backens M., Reith W., Meyer J., Falkai P. Association of the brain-derived neurotrophic factor val66met polymorphism with magnetic resonance spectroscopic markers in the human hippocampus: in vivo evidence for effects on the glutamate system. European Archives of Psychiatry and Clinical Neuroscience 2012, 262:23-31.
12. Han D.H., Park D.B., Choi T.Y., Joo S.Y., Lee M.K., Park B.R., Nishimura R., Chu C.C., Renshaw P.F. Effects of brain-derived neurotrophic factor-catecholamine-O-methyltransferase gene interaction on schizophrenic symptoms. NeuroReport 2008, 19:1155-1158.
13. Hashimoto T., Lewis D.A. BDNF Val66Met polymorphism and GAD67 mRNA expression in the prefrontal cortex of subjects with schizophrenia. The American Journal of Psychiatry 2006, 163:534-537.
14. Ho B.C., Milev P., O'Leary D.S., Librant A., Andreasen N.C., Wassink T.H. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Archives of General Psychiatry 2006, 63:731-740.
15. Hong C.J., Yu Y.W., Lin C.H., Tsai S.J. An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neuroscience Letters 2003, 349:206-208.
16. Huang T.L., Lee C.T. Associations between brain-derived neurotrophic factor G196A gene polymorphism and clinical phenotypes in schizophrenia patients. Chang Gung Medical Journal 2007, 30:408-413.
17. Jönsson E.G., Edman-Ahlbom B., Sillén A., Gunnar A., Kulle B., Frigessi A., Vares M., Ekholm B., Wode-Helgodt B., Schumacher J., Cichon S., Agartz I., Sedvall G.C., Hall H., Terenius L. Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2006, 30:924-933.
18. Kawashima K., Ikeda M., Kishi T., Kitajima T., Yamanouchi Y., Kinoshita Y., Okochi T., Aleksic B., Tomita M., Okada T., Kunugi H., Inada T., Ozaki N., Iwata N. BDNF is not associated with schizophrenia: data from a Japanese population study and meta-analysis. Schizophrenia Research 2009, 112:72-79.
19. Koolschijn P.C., van Haren N.E., Bakker S.C., Hoogendoorn M.L., Hulshoff Pol H.E., Kahn R.S. Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia. Hippocampus 2010, 20:1010-1017.
20. Loh H.C., Tang P.Y., Tee S.F., Chow T.J., Cheah Y.C., Singh S.S. BDNF and DARPP-32 genes are not risk factors for schizophrenia in the Malay population. Genetics and Molecular Research 2012, 11:725-730.
21. Lu W., Zhang C., Yi Z., Li Z., Wu Z., Fang Y. Association between BDNF Val66Met polymorphism and cognitive performance in antipsychotic-naive patients with schizophrenia. Journal of Molecular Neuroscience 2012, 47:505-510.
22. Nanko S., Kunugi H., Hirasawa H., Kato N., Nabika T., Kobayashi S. Brain-derived neurotrophic factor gene and schizophrenia: polymorphism screening and association analysis. Schizophrenia Research 2003, 62:281-283.
23. Naoe Y., Shinkai T., Hori H., Fukunaka Y., Utsunomiya K., Sakata S., Matsumoto C., Shimizu K., Hwang R., Ohmori O., Nakamura J. No association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and schizophrenia in Asian populations: evidence from a case-control study and meta-analysis. Neuroscience Letters 2007, 415:108-112.
24. Neves-Pereira M., Cheung J.K., Pasdar A., Zhang F., Breen G., Yates P., Sinclair M., Crombie C., Walker N., Clair D.M. BDNF gene is a risk factor for schizophrenia in a Scottish population. Molecular Psychiatry 2005, 10:208-212.
25. Numata S., Ueno S., Iga J., Yamauchi K., Hongwei S., Kinouchi S., Shibuya-Tayoshi S., Tayoshi S., Aki H., Sumitani S., Itakura M., Ohmori T. Interaction between catechol-O-methyltransferase (COMT) Val108/158Met and brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in age at onset and clinical symptoms in schizophrenia. Journal of Neural Transmission 2007, 114:255-259.
26. Park S.W., Lee J.G., Kong B.G., Lee S.J., Lee C.H., Kim J.I., Kim Y.H. Genetic association of BDNF val66met and GSK-3beta-50T/C polymorphisms with tardive dyskinesia. Psychiatry and Clinical Neurosciences 2009, 63:433-439.
27. Qian L., Zhao J., Shi Y., Zhao X., Feng G., Xu F., Zhu S., He L. Brain-derived neurotrophic factor and risk of schizophrenia: an association study and meta-analysis. Biochemical and Biophysical Research Communications 2007, 353:738-743.
28. Rybakowski J.K. BDNF gene: functional Val66Met polymorphism in mood disorders and schizophrenia. Pharmacogenomics 2008, 9:1589-1593.
29. Schumacher J., Jamra R.A., Becker T., Ohlraun S., Klopp N., Binder E.B., Schulze T.G., Deschner M., Schmäl C., Höfels S., Zobel A., Illig T., Propping P., Holsboer F., Rietschel M., Nöthen M.M., Cichon S. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biological Psychiatry 2005, 58:307-314.
30. Skibinska M., Hauser J., Czerski P.M., Leszczynska-Rodziewicz A., Kosmowska M., Kapelski P., Slopien A., Zakrzewska M., Rybakowski J.K. Association analysis of brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism in schizophrenia and bipolar affective disorder. The World Journal of Biological Psychiatry 2004, 5:215-220.
31. Sotiropoulou M., Mantas C., Bozidis P., Marselos M., Mavreas V., Hyphantis T., Antoniou K. BDNF serum concentrations in first psychotic episode drug-naive schizophrenic patients: associations with personality and BDNF Val66Met polymorphism. Life Sciences 2013, 92:305-310.
32. Suchanek R., Owczarek A., Paul-Samojedny M., Kowalczyk M., Kucia K., Kowalski J. BDNF val66met polymorphism is associated with age at onset and intensity of symptoms of paranoid schizophrenia in a Polish population. The Journal of Neuropsychiatry and Clinical Neurosciences 2013, 25:88-94.
33. Sun M.M., Yang L.M., Wang Y., Feng X., Cui K.Y., Liu L.F., Chen Z.Y. BDNF Val66Met polymorphism and anxiety/depression symptoms in schizophrenia in a Chinese Han population. Psychiatric Genetics 2013, 23:124-129.
34. Sun R.F., Zhu Y.S., Kuang W.J., Liu Y., Li S.B. The G-712A polymorphism of brain-derived neurotrophic factor is associated with major depression but not schizophrenia. Neuroscience Letters 2011, 489:34-37.
35. Szeszko P.R., Lipsky R., Mentschel C., Robinson D., Gunduz-Bruce H., Sevy S., Ashtari M., Napolitano B., Bilder R.M., Kane J.M., Goldman D., Malhotra A.K. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Molecular Psychiatry 2005, 10:631-636.
36. Takahashi T., Suzuki M., Tsunoda M., Kawamura Y., Takahashi N., Maeno N., Kawasaki Y., Zhou S.Y., Hagino H., Niu L., Tsuneki H., Kobayashi S., Sasaoka T., Seto H., Kurachi M., Ozaki N. The association of genotypic combination of the DRD3 and BDNF polymorphisms on the adhesio interthalamica and medial temporal lobe structures. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2008, 32:1236-1242.
37. Tan Y.L., Zhou D.F., Cao L.Y., Zou Y.Z., Wu G.Y., Zhang X.Y. Effect of the BDNF Val66Met genotype on episodic memory in schizophrenia. Schizophrenia Research 2005, 77:355-356.
38. Tochigi M., Otowa T., Suga M., Rogers M., Minato T., Yamasue H., Kasai K., Kato N., Sasaki T. No evidence for an association between the BDNF Val66Met polymorphism and schizophrenia or personality traits. Schizophrenia Research 2006, 87:45-47.
39. Watanabe Y., Muratake T., Kaneko N., Nunokawa A., Someya T. No association between the brain-derived neurotrophic factor gene and schizophrenia in a Japanese population. Schizophrenia Research 2006, 84:29-35.
40. Xu M.Q., Clair D., Ott J., Feng G.Y., He L. Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis. Schizophrenia Research 2007, 91:6-13.
41. Yi Z., Zhang C., Wu Z., Hong W., Li Z., Fang Y., Yu S. Lack of effect of brain derived neurotrophic factor (BDNF) Val66Met polymorphism on early onset schizophrenia in Chinese Han population. Brain Research 2011, 1417:146-150.
42. Zakharyan R., Boyajyan A., Arakelyan A., Gevorgyan A., Mrazek F., Petrek M. Functional variants of the genes involved in neurodevelopment and susceptibility to schizophrenia in an Armenian population. Human Immunology 2011, 72:746-748.
43. Zhang H., Ozbay F., Lappalainen J., Kranzler H.R., van Dyck C.H., Charney D.S., Price L.H., Southwick S., Yang B.Z., Rasmussen A., Gelernter J. Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 2006, 141B:387-393.
44. Zhang X.Y., Chen da C., Xiu M.H., Haile C.N., Luo X., Xu K., Zhang H.P., Zuo L., Zhang Z., Zhang X., Kosten T.A., Kosten T.R. Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls. Human Genetics 2012, 131:1187-1195.
45. Zhao X., Huang Y., Ma H., Jin Q., Wang Y., Zhu G. Association between major depressive disorder and the norepinephrine transporter polymorphisms T-182C and G1287A: a meta-analysis. Journal of Affective Disorders 2013, 150:23-28.
46. Zhou D.H., Yan Q.Z., Yan X.M., Li C.B., Fang H., Zheng Y.L., Zhang C.X., Yao H.J., Chen da C., Xiu M.H., Kosten T.R., Zhang X.Y. The study of BDNF Val66Met polymorphism in Chinese schizophrenic patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2010, 34:930-933.